TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
XGN

Exagen Inc

Healthcare · Diagnostics & Research

8.40$ +6.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement XGN
Line item 2013 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
92.6% 59.0% 53.1% 52.7% 47.4% 46.6% 39.4% 42.6% 53.1% 43.9% 40.5% 41.7%
7.4% 41.0% 46.9% 47.3% 52.6% 53.4% 60.6% 57.4% 46.9% 56.1% 59.5% 58.3%
29.4% 11.0% 7.6% 5.8% 6.6% 5.4% 8.5% 15.0% 21.7% 9.3% 9.7% 9.4%
214.9% 119.7% 88.6% 65.4% 56.3% 67.1% 85.1% 88.7% 107.6% 87.4% 71.8% 70.0%
265.3% 142.1% 106.2% 76.7% 67.6% 76.5% 96.7% 107.2% 147.9% 99.5% 84.0% 79.4%
-299.3% -99.1% -57.9% -29.2% -15.0% -23.0% -36.2% -49.8% -101.1% -43.5% -24.5% -21.1%
30.8% 25.2% 25.1% 11.0% 8.8% 8.6% 6.1% 5.4% 5.4% 4.4% 4.0% 6.5%
-440.4% -128.6% -105.5% -97.7% -24.5% -29.7% -39.9% -55.2% -104.6% -45.0% -27.1% -29.9%
1.4% -0.1% 1.4% -2.0% 0.2% 0.1% -0.2% 0.4% -0.6% 0.1% 0.0% 0.1%
-441.8% -128.4% -106.9% -95.6% -24.7% -29.8% -39.8% -55.6% -104.0% -45.1% -27.2% -30.0%
-394.7% -98.6% -75.5% -84.2% -13.4% -19.6% -32.5% -47.8% -95.8% -36.4% -20.0% -20.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?